Drug firm Alembic Pharmaceuticals on Monday said its subsidiary has received tentative approval from the US health regulator for Treprostinil injection indicated for the treatment of pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback